Literature DB >> 23525767

FDG PET/CT in children and adolescents with lymphoma.

Regine Kluge1, Lars Kurch, Françoise Montravers, Christine Mauz-Körholz.   

Abstract

The aim of this review is to give an overview of FDG PET/CT applications in children and adolescents with lymphoma. Today, FDG PET is used for tailoring treatment intensity in children with Hodgkin lymphoma within the framework of international treatment optimisation protocols. In contrast, the role of this method in children with Non-Hodgkin lymphoma is not well defined. This paper overviews clinical appearance and metabolic behaviour of the most frequent lymphoma subtypes in childhood. The main focus of the review is to summarise knowledge about the role of FDG PET/CT for initial staging and early response assessment.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23525767     DOI： 10.1007/s00247-012-2559-z

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN： 0301-0449


  83 in total

1.  Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.

Authors:  A Reiter; M Schrappe; W D Ludwig; M Tiemann; R Parwaresch; M Zimmermann; E Schirg; G Henze; G Schellong; H Gadner; H Riehm
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

2.  PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.

Authors:  Lale Kostakoglu; Morton Coleman; John P Leonard; Ichiei Kuji; Holly Zoe; Stanley J Goldsmith
Journal:  J Nucl Med       Date:  2002-08       Impact factor: 10.057

3.  Interim PET in lymphoma: a step towards standardization.

Authors:  Michel Meignan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-10       Impact factor: 9.236

4.  (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging.

Authors:  Gerard Moulin-Romsee; Elif Hindié; Xavier Cuenca; Pauline Brice; Didier Decaudin; Myriam Bénamor; Josette Brière; Marcela Anitei; Jean-Emmanuel Filmont; David Sibon; Eric de Kerviler; Jean-Luc Moretti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-04       Impact factor: 9.236

5.  Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.

Authors:  Christine Mauz-Körholz; Dirk Hasenclever; Wolfgang Dörffel; Kathrin Ruschke; Tanja Pelz; Antje Voigt; Martina Stiefel; Melanie Winkler; Constanze Vilser; Karin Dieckmann; Jonas Karlén; Eva Bergsträsser; Alexander Fosså; Georg Mann; Michael Hummel; Wolfram Klapper; Harald Stein; Dirk Vordermark; Regine Kluge; Dieter Körholz
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

6.  Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients.

Authors:  Gang Cheng; Wengen Chen; Wichana Chamroonrat; Drew A Torigian; Hongming Zhuang; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-20       Impact factor: 9.236

7.  Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook.

Authors:  W Dörffel; H Lüders; U Rühl; M Albrecht; H Marciniak; R Parwaresch; R Pötter; G Schellong; E-W Schwarze; L Wickmann
Journal:  Klin Padiatr       Date:  2003 May-Jun       Impact factor: 1.349

8.  18F-FDG PET and PET/CT in Burkitt's lymphoma.

Authors:  Dimitrios Karantanis; Jolanta M Durski; Val J Lowe; Mark A Nathan; Brian P Mullan; Evangelos Georgiou; Patrick B Johnston; Gregory A Wiseman
Journal:  Eur J Radiol       Date:  2009-08-27       Impact factor: 3.528

9.  Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas--the PETAL trial.

Authors:  Ulrich Dührsen; Andreas Hüttmann; Karl-Heinz Jöckel; Stefan Müller
Journal:  Leuk Lymphoma       Date:  2009-11

10.  On the added value of baseline FDG-PET in malignant lymphoma.

Authors:  Henriette Quarles van Ufford; Otto Hoekstra; Marie de Haas; Rob Fijnheer; Shulamiet Wittebol; Bianca Tieks; Mark Kramer; John de Klerk
Journal:  Mol Imaging Biol       Date:  2009-10-07       Impact factor: 3.488
View more
  12 in total

1.  PET/CT-guided treatment planning for paediatric cancer patients: a simulation study of proton and conventional photon therapy.

Authors:  J S Kornerup; N P Brodin; T Björk-Eriksson; C Birk Christensen; A Kiil-Berthelsen; M C Aznar; C Hollensen; E Markova; P Munck Af Rosenschöld
Journal:  Br J Radiol       Date:  2014-12-12       Impact factor: 3.039

2.  Quantitative analysis of image metrics for reduced and standard dose pediatric 18F-FDG PET/MRI examinations.

Authors:  Pietro Zucchetta; Marco Branchini; Alessandra Zorz; Valentina Bodanza; Diego Cecchin; Marta Paiusco; Franco Bui
Journal:  Br J Radiol       Date:  2019-01-23       Impact factor: 3.039

Review 3.  2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.

Authors:  John Freebody; Eva A Wegner; Monica A Rossleigh
Journal:  World J Radiol       Date:  2014-10-28

4.  Excellent Outcomes Following Response-based Omission of Radiotherapy in Children and Adolescents With Intermediate or High-risk Hodgkin Lymphoma.

Authors:  Nmazuo W Ozuah; Karen J Marcus; Ann S LaCasce; Amy L Billett
Journal:  J Pediatr Hematol Oncol       Date:  2018-08       Impact factor: 1.289

5.  International Pediatric Non-Hodgkin Lymphoma Response Criteria.

Authors:  John T Sandlund; R Paul Guillerman; Sherrie L Perkins; C Ross Pinkerton; Angelo Rosolen; Catherine Patte; Alfred Reiter; Mitchell S Cairo
Journal:  J Clin Oncol       Date:  2015-05-04       Impact factor: 44.544

6.  The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma.

Authors:  Deepa Bhojwani; Mary B McCarville; John K Choi; Jennifer Sawyer; Monika L Metzger; Hiroto Inaba; Andrew M Davidoff; Robert Gold; Barry L Shulkin; John T Sandlund
Journal:  Br J Haematol       Date:  2014-11-10       Impact factor: 6.998

7.  [Specific characteristics of chest X‑ray in childhood : Basics for radiologists].

Authors:  K Schneider
Journal:  Radiologe       Date:  2018-04       Impact factor: 0.635

8.  Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma.

Authors:  Maria Rosana Ponisio; Jonathan McConathy; Richard Laforest; Geetika Khanna
Journal:  Pediatr Radiol       Date:  2016-03-22

9.  Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CT.

Authors:  Linda Jorgov; Françoise Montravers; Sona Balogova; Christine Ragu; Hélène Pacquement; Thierry Leblanc; Samuel Abbou; Hubert Ducou-Lepointe; Judith Landman-Parker; Jean-Noёl Talbot
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-14       Impact factor: 9.236

10.  Whole-body [18F]-FDG-PET/MRI for staging of pediatric non-Hodgkin lymphoma: first results from a single-center evaluation.

Authors:  L Kurch; R Kluge; O Sabri; L Fischer; S Wendt; H Graf Einsiedel; S Starke; J-S Kühl; H Christiansen; F W Hirsch; I Sorge; C Roth
Journal:  EJNMMI Res       Date:  2021-07-03       Impact factor: 3.138
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.